510(k) K091724
K091724 is an FDA 510(k) premarket notification submitted by Becton, Dickinson & CO for the device "BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY". The FDA issued a decision of Substantially Equivalent on November 13, 2009. The device falls under product code MKZ (Dna Probe, Nucleic Acid Amplification, Chlamydia), a Class I device regulated under 21 CFR 866.3120. Becton, Dickinson & CO has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 13, 2009
- Date Received
- June 11, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dna Probe, Nucleic Acid Amplification, Chlamydia
- Device Class
- Class I
- Regulation Number
- 866.3120
- Review Panel
- MI
- Submission Type